VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 134 filers reported holding VIKING THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $909 | +599.2% | 82,099 | +924.4% | 0.01% | +900.0% |
Q2 2023 | $130 | +30.0% | 8,014 | -25.0% | 0.00% | 0.0% |
Q4 2022 | $100 | -100.0% | 10,684 | -86.5% | 0.00% | -50.0% |
Q1 2022 | $237,000 | -43.8% | 78,850 | -14.1% | 0.00% | 0.0% |
Q4 2021 | $422,000 | -31.4% | 91,797 | -6.3% | 0.00% | -33.3% |
Q3 2021 | $615,000 | +742.5% | 98,009 | +708.2% | 0.00% | – |
Q2 2021 | $73,000 | -89.7% | 12,127 | -90.4% | 0.00% | -100.0% |
Q4 2020 | $710,000 | -59.8% | 126,106 | -58.4% | 0.00% | -63.6% |
Q3 2020 | $1,765,000 | +255.1% | 303,228 | +339.8% | 0.01% | +175.0% |
Q2 2020 | $497,000 | -38.9% | 68,940 | -60.3% | 0.00% | -50.0% |
Q1 2020 | $813,000 | +69.0% | 173,732 | +189.7% | 0.01% | +100.0% |
Q4 2019 | $481,000 | -72.1% | 59,966 | -76.1% | 0.00% | -71.4% |
Q3 2019 | $1,726,000 | +688.1% | 250,884 | +849.3% | 0.01% | +600.0% |
Q2 2019 | $219,000 | +76.6% | 26,428 | +62.9% | 0.00% | +100.0% |
Q4 2018 | $124,000 | -76.4% | 16,221 | -46.2% | 0.00% | -75.0% |
Q3 2018 | $526,000 | – | 30,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |